retatrutide peptide obesity triple hormone receptor agonist Medscape | Retatrutide, Eli Lilly's first-in-class agonist, delivered meaningful weight loss at 80 weeks in all doses in the retatrutide triple hormone receptor agonist
Pay in 4 interest-free payments of $7.20 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24








:max_bytes(150000):strip_icc()/VWH-GettyImages-2178836417-ee318a41780b44e9af3ff47de83fafd7.jpg)

















